CoChat

New-generation full-spectrum endoscopy versus standard forward-viewing colonoscopy: a multicenter, randomized, tandem colonoscopy trial (J-FUSE Study)

Kudo, Toyoki, Saito, Yutaka, Ikematsu, Hiroaki, Hotta, Kinichi, Takeuchi, Yoji, Shimatani, Masaaki, Kawakami, Ken, Tamai, Naoto, Mori, Yuichi, Maeda, Yasuharu, Yamada, Masayoshi, Sakamoto, Taku, Matsuda, Takahisa, Imai, Kenichiro, Ito, Sayo, Hamada, Kenta, Fukata, Norimasa, Inoue, Takuya, Tajiri, Hisao, Yoshimura, Kenichi, Ishikawa, Hideki, Kudo, Shin-ei · 2018 · Gastrointestinal Endoscopy
Cited by 47

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIMS Although colonoscopy is the criterion standard for detection of colorectal adenomas, some adenomas are missed. Full-spectrum endoscopy (FUSE) allows for observation with a 330-degree angle of view, which is expected to decrease the miss rate. However, no consensus has been reached regarding the superiority of FUSE over standard forward-viewing colonoscopy (SFVC) for detection of adenomas; we therefore compared new-generation FUSE and SFVC regarding colorectal adenoma miss rate (AMR) in this, the first reported randomized control trial using new-generation FUSE. METHODS We enrolled individuals aged 40 to 75 years who had been referred for screening, surveillance, fecal occult blood test positivity, or symptoms in a prospective randomized trial of tandem colonoscopy in 8 institutions. Patients were randomly assigned (1:1) via computer-generated stratified randomization. Neither the endoscopists nor patients were blinded to the allocation. The primary endpoint was AMR per patient (AMR-PP). RESULTS We enrolled 345 patients and included 319 in the per-protocol analyses. AMR-PP was significantly lower with FUSE (11.7%; 95% confidence interval [CI], 8.0%-15.4%) than with SFVC (22.9%; 95% CI, 17.5%-28.3%; P < .001). AMR-PP for lesions ≤5 mm in size was significantly lower with FUSE (10.4%; 95% CI, 6.5%-14.3%) than with SFVC (20.0%; 95% CI, 14.4%-25.6%; P = .0057). Furthermore, AMR-PP in the ascending colon was significantly lower with FUSE (4.3%; 95% CI, 1.4%-7.2%) than with SFVC (10.6%; 95% CI, 6.1%-15.1%; P = .0212). CONCLUSIONS FUSE is superior to SFVC regarding both AMR-PP and AMR; additionally, AMR-PP is both significantly lower with FUSE than SFVC for lesions ≤5 mm in size and in the ascending colon. (Clinical trial registration number: UMIN000020448.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gie.2018.06.011

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 47

Metadata

Authors
Kudo, T., Saito, Y., Ikematsu, H., Hotta, K., Takeuchi, Y., Shimatani, M., Kawakami, K., Tamai, N., Mori, Y., Maeda, Y., Yamada, M., Sakamoto, T., Matsuda, T., Imai, K., Ito, S., Hamada, K., Fukata, N., Inoue, T., Tajiri, H., Yoshimura, K., Ishikawa, H., & Kudo, S.-E.
Venue
Gastrointestinal Endoscopy
Publisher
Elsevier BV
Published
2018-11
Volume
88
Issue
5
Pages
854-864
ISSN
0016-5107 (ISSN-L)
OpenAlex
W2807829457
Cited by
47
References
5
FWCI
1.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New-generation full-spectrum endoscopy versus standard forward-viewing colonoscopy: a multicenter, randomized, tandem colonoscopy trial (J-FUSE Study). https://app.cochat.ai/papers/10.1016/j.gie.2018.06.011
The paper
Kudo, T., Saito, Y., Ikematsu, H., Hotta, K., Takeuchi, Y., Shimatani, M., Kawakami, K., Tamai, N., Mori, Y., Maeda, Y., Yamada, M., Sakamoto, T., Matsuda, T., Imai, K., Ito, S., Hamada, K., Fukata, N., Inoue, T., Tajiri, H., . . . Kudo, S.-E. (2018). New-generation full-spectrum endoscopy versus standard forward-viewing colonoscopy: a multicenter, randomized, tandem colonoscopy trial (J-FUSE Study). Gastrointestinal Endoscopy. https://doi.org/10.1016/j.gie.2018.06.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.